SCHEMBL20047027

SCHEMBL20047027

COc1ccc(-c2ccc3c(c2)CCN(S(=O)(=O)c2c(C)cc(I)cc2C)C3)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 3/20 0.51
AKR1C3 P42330 3/20 0.47
PDE4B Q07343 1/20 0.44
PDE4D Q08499 1/20 0.44
LMNA P02545 1/20 0.42
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 2/20 0.41
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
USP30 Q70CQ3 1/20 0.40
DRD1 P21728 1/20 0.39
DRD5 P21918 1/20 0.39
AKR1C1 Q04828 1/20 0.39
ABCB1 P08183 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20047173 0.91 PKM (0.53) PKMAKR1C3PDE4BPDE4DLMNA
SCHEMBL20047023 0.91 AKR1C3 (0.49) PKMAKR1C3ALDH1A1SMN1; SMN2MEN1
SCHEMBL20047024 0.86 CHRM5 (0.41) PKMAKR1C3LMNAALDH1A1ESR1
SCHEMBL20047021 0.84 AKR1C3 (0.45) AKR1C3LMNAKDM4EESR1ESR2
SCHEMBL20047028 0.83 SMN1; SMN2 (0.47) PKMAKR1C3PDE4BPDE4DLMNA
SCHEMBL20047020 0.83 MEN1 (0.40) AKR1C3LMNAESR1ESR2MEN1
SCHEMBL20047019 0.82 MEN1 (0.40) AKR1C3LMNAESR1ESR2MEN1
SCHEMBL20047032 0.82 KMT2A (0.47) AKR1C3LMNAESR1ESR2MEN1
SCHEMBL20047172 0.82 TMEM97 (0.51) PKMAKR1C3LMNASMN1; SMN2MEN1
SCHEMBL20047029 0.80 CYP11B1 (0.50) CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017223514-A9 LXR INVERSE AGONISTS FOR TREATMENT OF CANCER SAINT LOUIS UNIVERSITY (US) 2018-04-12 WO disclosed